Business Context and Reporting Period
This Form 8-K was filed by Eyenovia, Inc. (not Hyperion Defi, Inc.) on February 24, 2025, reporting events occurring on February 21, 2025. The filing details a material definitive agreement regarding the company's existing debt facility.
Key Financial Metrics and Debt Structure
- Outstanding Debt: As of February 21, 2025, the company owed $10.3 million in principal and accrued interest under a Loan and Security Agreement.
- Interest Rate: The annual rate is the greater of 7.0% or the Prime Rate plus 4.45%.
- Maturity Date: November 1, 2025.
- Payment Deferral: Principal and interest payments have been deferred until the end of September 2025. Deferred interest continues to accrue.
- Conversion Option: Lenders have the right, starting April 1, 2025, to convert up to $10 million of principal into common stock at a fixed price of $1.68 per share.
Material Changes and New Obligations
The Second Amendment introduces a mandatory repayment mechanism tied to the company's At-The-Market (ATM) offering program:
- Pre-$3M Raised: 65% of net ATM proceeds must be used to pay down the loan principal.
- Post-$3M Raised: 75% of net ATM proceeds must be used to pay down the loan principal.
This structure prioritizes debt reduction over other uses of capital raised through the ATM program.
Guidance, Risks, and Contingencies
The filing does not provide updated revenue guidance or management commentary on operational performance. Key risks and contingencies identified include:
- Liquidity Pressure: The mandatory diversion of ATM proceeds to debt service limits the company's ability to use new equity capital for operations or R&D.
- Dilution Risk: The lender's option to convert $10 million of debt at $1.68 per share could result in significant dilution to existing shareholders if exercised.
- Accrued Interest: While payments are deferred, interest continues to accrue, increasing the total debt burden over time.
Investor Verification Checklist
- Verify the current market price of Eyenovia stock relative to the $1.68 conversion price to assess immediate dilution risk.
- Review the company's recent 10-K or 10-Q to determine current cash balances and runway given the deferral of payments.
- Monitor the volume of shares sold under the ATM program to estimate the rate of debt paydown.
- Confirm the exact amount of accrued interest added to the principal balance since the last reporting period.